Parkinson's Disease Treatment - Global Market Outlook (2017-2026)

  • ID: 4541429
  • Report
  • Region: Global
  • 137 pages
  • Stratistics Market Research Consulting Pvt Ltd
1 of 4

FEATURED COMPANIES

  • Abbvie
  • Boehringer Ingelheim
  • GlaxoSmithKline Plc.
  • Lundbeck
  • Novartis
  • Sun Pharma
  • MORE
According to the publisher, the Global Parkinson'S Disease Treatment market is accounted for $4.08 billion in 2017 and is expected to reach $7.93 billion by 2026 growing at a CAGR of 7.7%. Growing geriatric population coupled with neurological disorders, increasing investments in research & development activities, and raising healthcare awareness are some of the factors propelling the market growth during the forecast period. However, availability of other treatments is hindering the market growth.

By therapeutic class, Carbidopa/Levodopa segment is prognosticated to witness strong growth rate over the forecast period due to its potentiality and large acceptance for the parkinson’s disease treatment. Besides, online pharmacies are projected to grow at a higher growth rate during the forecast period.

By region, Asia Pacific is expected to witness highest growth rate due to growing medical tourism trend and raising medical infrastructure. Europe is dominating the global market with highest market revenue during the forecast period. This dominance is driven by increasing geriatric population and raising expenses on healthcare.

Some of the key players in Parkinson’s disease Treatment market include GlaxoSmithKline Plc., Abbvie, Acadia, Boehringer Ingelheim, Daiichi Sankyo, Impax Laboratories, Inc., Lundbeck, Merck, Novartis, Salix Pharmaceuticals, Sun Pharma, Teva Pharmaceutical Industries Ltd., UCB, Valeant Pharmaceuticals, and Wockhardt Limited.

Therapeutic Class:
  • Monoamine oxidase B inhibitors (MAO-B inhibitors)
  • Dopamine precursors
  • Dopamine agonists (non-ergoline)
  • Catechol-O-methyl transferase (COMT) inhibitors
  • Carbidopa/Levodopa
  • Other Therapeutic Classes
Medical Devices:
  • Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices
  • Deep Brain Stimulation (DBS) Devices
Patient Care Setting:
  • Hospitals
  • Clinics
Distribution Channel:
  • Retail pharmacies
  • Online pharmacies
  • Hospital pharmacies
  • Drug stores
Regions Covered:
  • North America
o US
o Canada
o Mexico
  • Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
  • Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
  • South America
o Argentina
o Brazil
o Chile
o Rest of South America
  • Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
  • Market share assessments for the regional and country level segments
  • Market share analysis of the top industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbvie
  • Boehringer Ingelheim
  • GlaxoSmithKline Plc.
  • Lundbeck
  • Novartis
  • Sun Pharma
  • MORE
1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Parkinson'S Disease Treatment Market, By Therapeutic Class
5.1 Introduction
5.2 Monoamine oxidase B inhibitors (MAO-B inhibitors)
5.2.1 Rasagiline
5.2.2 Selegiline
5.3 Dopamine precursors
5.3.1 Primidone
5.3.2 Phenobarbital
5.4 Dopamine agonists (non-ergoline)
5.4.1 Ropinirole
5.4.2 Pramipexole
5.4.3 Others (apomorphine and rotigotine)
5.5 Catechol-O-methyl transferase (COMT) inhibitors
5.5.1 Tolcapone
5.5.2 Entacapone
5.6 Carbidopa/Levodopa
5.7 Other Therapeutic Classes
5.7.1 Amantadine and Anticholinergic

6 Global Parkinson'S Disease Treatment Market, By Medical Devices
6.1 Introduction
6.2 Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices
6.3 Deep Brain Stimulation (DBS) Devices

7 Global Parkinson'S Disease Treatment Market, By Patient Care Setting
7.1 Introduction
7.2 Hospitals
7.3 Clinics

8 Global Parkinson'S Disease Treatment Market, By Distribution Channel
8.1 Introduction
8.2 Retail pharmacies
8.3 Online pharmacies
8.4 Hospital pharmacies
8.5 Drug stores

9 Global Parkinson'S Disease Treatment Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Leading Companies
11.1 GlaxoSmithKline Plc.
11.2 Abbvie
11.3 Acadia
11.4 Boehringer Ingelheim
11.5 Daiichi Sankyo
11.6 Impax Laboratories, Inc.
11.7 Lundbeck
11.8 Merck
11.9 Novartis
11.10 Salix Pharmaceuticals
11.11 Sun Pharma
11.12 Teva Pharmaceutical Industries Ltd.
11.13 UCB
11.14 Valeant Pharmaceuticals
11.15 Wockhardt Limited

List of Tables
Table 1 Global Parkinson'S Disease Treatment Market By Region, Market Forecast (2016-2026) (US $MN)
Table 2 Global Parkinson'S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
Table 3 Global Parkinson'S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
Table 4 Global Parkinson'S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
Table 5 Global Parkinson'S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
Table 6 Global Parkinson'S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
Table 7 Global Parkinson'S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
Table 8 Global Parkinson'S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
Table 9 Global Parkinson'S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
Table 10 Global Parkinson'S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
Table 11 Global Parkinson'S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
Table 12 Global Parkinson'S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
Table 13 Global Parkinson'S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
Table 14 Global Parkinson'S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
Table 15 Global Parkinson'S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
Table 16 Global Parkinson'S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
Table 17 Global Parkinson'S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
Table 18 Global Parkinson'S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
Table 19 Global Parkinson'S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
Table 20 Global Parkinson'S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
Table 21 Global Parkinson'S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
Table 22 Global Parkinson'S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
Table 23 Global Parkinson'S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
Table 24 Global Parkinson'S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
Table 25 Global Parkinson'S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
Table 26 Global Parkinson'S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
Table 27 Global Parkinson'S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
Table 28 Global Parkinson'S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
Table 29 Global Parkinson'S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
Table 30 North America Parkinson'S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
Table 31 North America Parkinson'S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
Table 32 North America Parkinson'S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
Table 33 North America Parkinson'S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
Table 34 North America Parkinson'S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
Table 35 North America Parkinson'S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
Table 36 North America Parkinson'S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
Table 37 North America Parkinson'S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
Table 38 North America Parkinson'S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
Table 39 North America Parkinson'S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
Table 40 North America Parkinson'S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
Table 41 North America Parkinson'S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
Table 42 North America Parkinson'S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
Table 43 North America Parkinson'S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
Table 44 North America Parkinson'S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
Table 45 North America Parkinson'S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
Table 46 North America Parkinson'S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
Table 47 North America Parkinson'S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
Table 48 North America Parkinson'S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
Table 49 North America Parkinson'S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
Table 50 North America Parkinson'S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
Table 51 North America Parkinson'S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
Table 52 North America Parkinson'S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
Table 53 North America Parkinson'S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
Table 54 North America Parkinson'S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
Table 55 North America Parkinson'S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
Table 56 North America Parkinson'S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
Table 57 North America Parkinson'S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
Table 58 North America Parkinson'S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
Table 59 Europe Parkinson'S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
Table 60 Europe Parkinson'S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
Table 61 Europe Parkinson'S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
Table 62 Europe Parkinson'S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
Table 63 Europe Parkinson'S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
Table 64 Europe Parkinson'S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
Table 65 Europe Parkinson'S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
Table 66 Europe Parkinson'S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
Table 67 Europe Parkinson'S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
Table 68 Europe Parkinson'S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
Table 69 Europe Parkinson'S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
Table 70 Europe Parkinson'S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
Table 71 Europe Parkinson'S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
Table 72 Europe Parkinson'S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
Table 73 Europe Parkinson'S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
Table 74 Europe Parkinson'S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
Table 75 Europe Parkinson'S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
Table 76 Europe Parkinson'S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
Table 77 Europe Parkinson'S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
Table 78 Europe Parkinson'S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
Table 79 Europe Parkinson'S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
Table 80 Europe Parkinson'S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
Table 81 Europe Parkinson'S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
Table 82 Europe Parkinson'S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
Table 83 Europe Parkinson'S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
Table 84 Europe Parkinson'S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
Table 85 Europe Parkinson'S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
Table 86 Europe Parkinson'S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
Table 87 Europe Parkinson'S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
Table 88 Asia Pacific Parkinson'S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
Table 89 Asia Pacific Parkinson'S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
Table 90 Asia Pacific Parkinson'S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
Table 91 Asia Pacific Parkinson'S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
Table 92 Asia Pacific Parkinson'S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
Table 93 Asia Pacific Parkinson'S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
Table 94 Asia Pacific Parkinson'S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
Table 95 Asia Pacific Parkinson'S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
Table 96 Asia Pacific Parkinson'S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
Table 97 Asia Pacific Parkinson'S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
Table 98 Asia Pacific Parkinson'S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
Table 99 Asia Pacific Parkinson'S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
Table 100 Asia Pacific Parkinson'S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
Table 101 Asia Pacific Parkinson'S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
Table 102 Asia Pacific Parkinson'S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
Table 103 Asia Pacific Parkinson'S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
Table 104 Asia Pacific Parkinson'S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
Table 105 Asia Pacific Parkinson'S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
Table 106 Asia Pacific Parkinson'S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
Table 107 Asia Pacific Parkinson'S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
Table 108 Asia Pacific Parkinson'S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
Table 109 Asia Pacific Parkinson'S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
Table 110 Asia Pacific Parkinson'S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
Table 111 Asia Pacific Parkinson'S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
Table 112 Asia Pacific Parkinson'S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
Table 113 Asia Pacific Parkinson'S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
Table 114 Asia Pacific Parkinson'S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
Table 115 Asia Pacific Parkinson'S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
Table 116 Asia Pacific Parkinson'S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
Table 117 South America Parkinson'S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
Table 118 South America Parkinson'S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
Table 119 South America Parkinson'S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
Table 120 South America Parkinson'S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
Table 121 South America Parkinson'S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
Table 122 South America Parkinson'S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
Table 123 South America Parkinson'S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
Table 124 South America Parkinson'S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
Table 125 South America Parkinson'S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
Table 126 South America Parkinson'S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
Table 127 South America Parkinson'S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
Table 128 South America Parkinson'S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
Table 129 South America Parkinson'S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
Table 130 South America Parkinson'S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
Table 131 South America Parkinson'S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
Table 132 South America Parkinson'S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
Table 133 South America Parkinson'S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
Table 134 South America Parkinson'S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
Table 135 South America Parkinson'S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
Table 136 South America Parkinson'S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
Table 137 South America Parkinson'S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
Table 138 South America Parkinson'S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
Table 139 South America Parkinson'S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
Table 140 South America Parkinson'S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
Table 141 South America Parkinson'S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
Table 142 South America Parkinson'S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
Table 143 South America Parkinson'S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
Table 144 South America Parkinson'S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
Table 145 South America Parkinson'S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
Table 146 Middle East & Africa Parkinson'S Disease Treatment Market By Country, Market Forecast (2016-2026) (US $MN)
Table 147 Middle East & Africa Parkinson'S Disease Treatment Market By Therapeutic Class, Market Forecast (2016-2026) (US $MN)
Table 148 Middle East & Africa Parkinson'S Disease Treatment Market By Monoamine oxidase B inhibitors (MAO-B inhibitors), Market Forecast (2016-2026) (US $MN)
Table 149 Middle East & Africa Parkinson'S Disease Treatment Market By Rasagiline, Market Forecast (2016-2026) (US $MN)
Table 150 Middle East & Africa Parkinson'S Disease Treatment Market By Selegiline, Market Forecast (2016-2026) (US $MN)
Table 151 Middle East & Africa Parkinson'S Disease Treatment Market By Dopamine precursors, Market Forecast (2016-2026) (US $MN)
Table 152 Middle East & Africa Parkinson'S Disease Treatment Market By Primidone, Market Forecast (2016-2026) (US $MN)
Table 153 Middle East & Africa Parkinson'S Disease Treatment Market By Phenobarbital, Market Forecast (2016-2026) (US $MN)
Table 154 Middle East & Africa Parkinson'S Disease Treatment Market By Dopamine agonists (non-ergoline), Market Forecast (2016-2026) (US $MN)
Table 155 Middle East & Africa Parkinson'S Disease Treatment Market By Ropinirole, Market Forecast (2016-2026) (US $MN)
Table 156 Middle East & Africa Parkinson'S Disease Treatment Market By Pramipexole, Market Forecast (2016-2026) (US $MN)
Table 157 Middle East & Africa Parkinson'S Disease Treatment Market By Others (apomorphine and rotigotine), Market Forecast (2016-2026) (US $MN)
Table 158 Middle East & Africa Parkinson'S Disease Treatment Market By Catechol-O-methyl transferase (COMT) inhibitors, Market Forecast (2016-2026) (US $MN)
Table 159 Middle East & Africa Parkinson'S Disease Treatment Market By Tolcapone, Market Forecast (2016-2026) (US $MN)
Table 160 Middle East & Africa Parkinson'S Disease Treatment Market By Entacapone, Market Forecast (2016-2026) (US $MN)
Table 161 Middle East & Africa Parkinson'S Disease Treatment Market By Carbidopa/Levodopa, Market Forecast (2016-2026) (US $MN)
Table 162 Middle East & Africa Parkinson'S Disease Treatment Market By Other Therapeutic Classes, Market Forecast (2016-2026) (US $MN)
Table 163 Middle East & Africa Parkinson'S Disease Treatment Market By Amantadine and Anticholinergic, Market Forecast (2016-2026) (US $MN)
Table 164 Middle East & Africa Parkinson'S Disease Treatment Market By Medical Devices, Market Forecast (2016-2026) (US $MN)
Table 165 Middle East & Africa Parkinson'S Disease Treatment Market By Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices, Market Forecast (2016-2026) (US $MN)
Table 166 Middle East & Africa Parkinson'S Disease Treatment Market By Deep Brain Stimulation (DBS) Devices, Market Forecast (2016-2026) (US $MN)
Table 167 Middle East & Africa Parkinson'S Disease Treatment Market By Patient Care Setting, Market Forecast (2016-2026) (US $MN)
Table 168 Middle East & Africa Parkinson'S Disease Treatment Market By Hospitals, Market Forecast (2016-2026) (US $MN)
Table 169 Middle East & Africa Parkinson'S Disease Treatment Market By Clinics, Market Forecast (2016-2026) (US $MN)
Table 170 Middle East & Africa Parkinson'S Disease Treatment Market By Distribution Channel, Market Forecast (2016-2026) (US $MN)
Table 171 Middle East & Africa Parkinson'S Disease Treatment Market By Retail pharmacies, Market Forecast (2016-2026) (US $MN)
Table 172 Middle East & Africa Parkinson'S Disease Treatment Market By Online pharmacies, Market Forecast (2016-2026) (US $MN)
Table 173 Middle East & Africa Parkinson'S Disease Treatment Market By Hospital pharmacies, Market Forecast (2016-2026) (US $MN)
Table 174 Middle East & Africa Parkinson'S Disease Treatment Market By Drug stores, Market Forecast (2016-2026) (US $MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • GlaxoSmithKline Plc.
  • Abbvie
  • Acadia
  • Boehringer Ingelheim
  • Daiichi Sankyo
  • Impax Laboratories, Inc.
  • Lundbeck
  • Merck
  • Novartis
  • Salix Pharmaceuticals
  • Sun Pharma
  • Teva Pharmaceutical Industries Ltd.
  • UCB
  • Valeant Pharmaceuticals
  • Wockhardt Limited
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll